119 related articles for article (PubMed ID: 22876713)
1. [Liver diseases in rheumatoid and psoriatic arthritis].
Santiago García D; Saturansky E; Poncino D; Ortiz V; Martínez Artola Y; Rosenberg S; Abritta G; Palermo C; Enriquez N; Cravero A
Acta Gastroenterol Latinoam; 2012 Jun; 42(2):112-9. PubMed ID: 22876713
[TBL] [Abstract][Full Text] [Related]
2. "Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?".
García DS; Saturansky EI; Poncino D; Martínez-Artola Y; Rosenberg S; Abritta G; Ascimani-Peña C; Cravero A
Ann Hepatol; 2019; 18(5):765-769. PubMed ID: 31105018
[TBL] [Abstract][Full Text] [Related]
3. Hepatoprotective effect of tumour necrosis factor alpha blockade in psoriatic arthritis: a cross-sectional study.
Seitz M; Reichenbach S; Möller B; Zwahlen M; Villiger PM; Dufour JF
Ann Rheum Dis; 2010 Jun; 69(6):1148-50. PubMed ID: 19854710
[TBL] [Abstract][Full Text] [Related]
4. Comment on: Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
Lynch M; Kirby B
Rheumatology (Oxford); 2010 Jan; 49(1):196-7; author reply 197-8. PubMed ID: 19858119
[No Abstract] [Full Text] [Related]
5. Hepatotoxicity of prolonged methotrexate therapy for rheumatoid arthritis.
Mackenzie AH
Cleve Clin Q; 1985; 52(2):129-35. PubMed ID: 4028418
[No Abstract] [Full Text] [Related]
6. Concomitant use of low-dose methotrexate and NSAIDs and the risk of serious adverse events among patients with rheumatoid arthritis.
Svanström H; Lund M; Melbye M; Pasternak B
Pharmacoepidemiol Drug Saf; 2018 Aug; 27(8):885-893. PubMed ID: 29797447
[TBL] [Abstract][Full Text] [Related]
7. Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
Amital H; Arnson Y; Chodick G; Shalev V
Rheumatology (Oxford); 2009 Sep; 48(9):1107-10. PubMed ID: 19578136
[TBL] [Abstract][Full Text] [Related]
8. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
Kapetanovic MC; Roseman C; Jönsson G; Truedsson L; Saxne T; Geborek P
Arthritis Rheum; 2011 Dec; 63(12):3723-32. PubMed ID: 21834061
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate and non-steroidal anti-inflammatory drugs.
Zachariae H
Br J Dermatol; 1992 Jan; 126(1):95. PubMed ID: 1536775
[No Abstract] [Full Text] [Related]
10. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
Sante; 2001; 11(3):195-200. PubMed ID: 11641084
[TBL] [Abstract][Full Text] [Related]
11. Clinical liver disease in patients with rheumatoid arthritis taking methotrexate.
Phillips CA; Cera PJ; Mangan TF; Newman ED
J Rheumatol; 1992 Feb; 19(2):229-33. PubMed ID: 1629819
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.
Miele L; Vallone S; Cefalo C; La Torre G; Di Stasi C; Vecchio FM; D'Agostino M; Gabrieli ML; Vero V; Biolato M; Pompili M; Gasbarrini G; Rapaccini G; Amerio P; De Simone C; Grieco A
J Hepatol; 2009 Oct; 51(4):778-86. PubMed ID: 19664838
[TBL] [Abstract][Full Text] [Related]
13. Liver steatosis is a risk factor for hepatotoxicity in patients with inflammatory bowel disease under immunosuppressive treatment.
Schröder T; Schmidt KJ; Olsen V; Möller S; Mackenroth T; Sina C; Lehnert H; Fellermann K; Büning J
Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):698-704. PubMed ID: 25923946
[TBL] [Abstract][Full Text] [Related]
14. Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study.
Chen YJ; Chang YT; Shen JL; Chen TT; Wang CB; Chen CM; Wu CY
Arthritis Rheum; 2012 Jun; 64(6):1879-87. PubMed ID: 22161801
[TBL] [Abstract][Full Text] [Related]
15. Adverse drug reactions and organ damage: The liver.
Licata A
Eur J Intern Med; 2016 Mar; 28():9-16. PubMed ID: 26827101
[TBL] [Abstract][Full Text] [Related]
16. Treatment Patterns of Multimorbid Patients with Rheumatoid Arthritis: Results from an International Cross-sectional Study.
Radner H; Yoshida K; Hmamouchi I; Dougados M; Smolen JS; Solomon DH
J Rheumatol; 2015 Jul; 42(7):1099-104. PubMed ID: 26034147
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced liver injury.
Leise MD; Poterucha JJ; Talwalkar JA
Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
[TBL] [Abstract][Full Text] [Related]
18. [Use of NSAIDs in rheumatoid arthritis should be limited].
Lindberg M
Ugeskr Laeger; 2013 Apr; 175(15):1039-41. PubMed ID: 23582126
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune hepatitis as an adverse effect of long-term methotrexate therapy.
Ksouda K; Affes H; Atheymen R; Ezzeddine M; Zeghal K; Hammami S
Indian J Pharmacol; 2014; 46(6):649-50. PubMed ID: 25538339
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
